Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
How I treat rituximab refractory patients with WM.
Imprint
Impressum
|
Prof. Dr. C. Buske 89081 Ulm/Germany |
phone: +49-731-500 65 801 |
Content responsible person in accordance to § 5 TMG and § 55 Abs. 2 RStV:
Prof. Dr. C. Buske (address as above)
Liability Note
Despite careful control we assume no liability for the content of external links. The content of the linked pages is the site operator’s responsibility.
Copyright
All images, logos and texts on these sites are property of “Comprehensive Cancer Center Ulm” and their partners. The reproduction and/or proliferation of the given content in any form require the written approval of “Comprehensive Cancer Center Ulm”.
Realisation
MJU.media Internetlösungen (www.mju-media.de)